Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis: Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Number of pages1
JournalInternational Journal of Advances in Rheumatology
Volume8
Issue number3
StatePublished - Dec 1 2010

ASJC Scopus subject areas

  • Rheumatology

Cite this